Casey Woodring
Stock Analyst at JP Morgan
(0.75)
# 4,032
Out of 5,172 analysts
63
Total ratings
22.22%
Success rate
-14.94%
Average return
Main Sectors:
Stocks Rated by Casey Woodring
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TEM Tempus AI | Maintains: Neutral | $80 → $60 | $46.96 | +27.77% | 2 | Feb 25, 2026 | |
| GH Guardant Health | Maintains: Overweight | $120 → $130 | $85.18 | +52.62% | 3 | Feb 20, 2026 | |
| IQV IQVIA Holdings | Maintains: Overweight | $255 → $225 | $166.07 | +35.49% | 2 | Feb 6, 2026 | |
| ILMN Illumina | Maintains: Neutral | $130 → $120 | $124.33 | -3.48% | 3 | Feb 6, 2026 | |
| QGEN Qiagen | Maintains: Overweight | $55 → $60 | $39.93 | +50.26% | 5 | Feb 6, 2026 | |
| NTRA Natera | Maintains: Overweight | $250 → $260 | $195.28 | +33.14% | 3 | Dec 15, 2025 | |
| CRL Charles River Laboratories International | Maintains: Neutral | $165 → $190 | $153.60 | +23.70% | 10 | Dec 15, 2025 | |
| BRKR Bruker | Maintains: Overweight | $50 → $55 | $33.35 | +64.92% | 1 | Dec 15, 2025 | |
| BLLN BillionToOne | Maintains: Overweight | $150 → $145 | $76.00 | +90.79% | 2 | Dec 10, 2025 | |
| A Agilent Technologies | Maintains: Overweight | $165 → $180 | $111.30 | +61.73% | 2 | Nov 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $26 → $22 | $15.24 | +44.36% | 5 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $13 → $15 | $18.39 | -18.43% | 1 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $16 | $13.50 | +18.52% | 3 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $14 → $12 | $7.51 | +59.79% | 1 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $78 | $75.41 | +3.43% | 6 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $300 → $325 | $298.99 | +8.70% | 1 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $600 → $650 | $474.39 | +37.02% | 1 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1,200 → $1,285 | $1,204.48 | +6.69% | 1 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $265 → $150 | $99.70 | +50.45% | 6 | Apr 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $7 → $6 | $2.95 | +103.39% | 3 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $25 → $23 | $24.02 | -4.25% | 2 | Oct 31, 2023 |
Tempus AI
Feb 25, 2026
Maintains: Neutral
Price Target: $80 → $60
Current: $46.96
Upside: +27.77%
Guardant Health
Feb 20, 2026
Maintains: Overweight
Price Target: $120 → $130
Current: $85.18
Upside: +52.62%
IQVIA Holdings
Feb 6, 2026
Maintains: Overweight
Price Target: $255 → $225
Current: $166.07
Upside: +35.49%
Illumina
Feb 6, 2026
Maintains: Neutral
Price Target: $130 → $120
Current: $124.33
Upside: -3.48%
Qiagen
Feb 6, 2026
Maintains: Overweight
Price Target: $55 → $60
Current: $39.93
Upside: +50.26%
Natera
Dec 15, 2025
Maintains: Overweight
Price Target: $250 → $260
Current: $195.28
Upside: +33.14%
Charles River Laboratories International
Dec 15, 2025
Maintains: Neutral
Price Target: $165 → $190
Current: $153.60
Upside: +23.70%
Bruker
Dec 15, 2025
Maintains: Overweight
Price Target: $50 → $55
Current: $33.35
Upside: +64.92%
BillionToOne
Dec 10, 2025
Maintains: Overweight
Price Target: $150 → $145
Current: $76.00
Upside: +90.79%
Agilent Technologies
Nov 25, 2025
Maintains: Overweight
Price Target: $165 → $180
Current: $111.30
Upside: +61.73%
Nov 7, 2025
Maintains: Underweight
Price Target: $26 → $22
Current: $15.24
Upside: +44.36%
Nov 7, 2025
Maintains: Neutral
Price Target: $13 → $15
Current: $18.39
Upside: -18.43%
Nov 5, 2025
Maintains: Neutral
Price Target: $14 → $16
Current: $13.50
Upside: +18.52%
Oct 30, 2025
Downgrades: Neutral
Price Target: $14 → $12
Current: $7.51
Upside: +59.79%
Oct 22, 2025
Downgrades: Neutral
Price Target: $78
Current: $75.41
Upside: +3.43%
Oct 9, 2025
Maintains: Neutral
Price Target: $300 → $325
Current: $298.99
Upside: +8.70%
Oct 9, 2025
Maintains: Overweight
Price Target: $600 → $650
Current: $474.39
Upside: +37.02%
Oct 9, 2025
Maintains: Neutral
Price Target: $1,200 → $1,285
Current: $1,204.48
Upside: +6.69%
Apr 29, 2025
Downgrades: Neutral
Price Target: $265 → $150
Current: $99.70
Upside: +50.45%
May 13, 2024
Maintains: Neutral
Price Target: $7 → $6
Current: $2.95
Upside: +103.39%
Oct 31, 2023
Maintains: Neutral
Price Target: $25 → $23
Current: $24.02
Upside: -4.25%